TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
CTOR

Citius Oncology, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

1.10$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CTOR
Line item 2021 2022 2023 2024 2025
– 0.00 0.00 0.00 0.00
– 0.08 0.05 0.07 0.09
– 0.03 0.09 0.22 0.23
– 0.11 0.14 0.29 0.32
– -0.11 -0.14 -0.29 -0.32
– – – 0.00 0.00
0.00 -0.11 -0.14 -0.29 -0.32
– 0.01 0.01 0.01 0.01
0.00 -0.12 -0.14 -0.30 -0.34
0.00 -0.05 -0.14 -0.29 -0.32

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?